Retatrutide is a new treatment in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By stimulating these receptors, Retatrutide suppresses appetite, {promotesglucose regulation, and ultimately lead